Vasculoprotective effects of pomegranate (Punica granatumL.). Front Pharmacol. 2018; 9: 544

D Wang, C Özen, IM Abu-Reidah, S Chigurupati, JK Patra, JO Horbanczuk, A Jóźwik, NT Tzvetkov, P Uhrin, AG Atanasov

2018-01-01

Abstract:

What problem does this paper attempt to address?

AG Atanasov Vasculoprotective effects of pomegranate (Punica granatum L.)., 2018, 9

D Wang, C Özen, IM Abu-Reidah, S Chigurupati, JK Patra, JO Horbanczuk, A Jóźwik, NT Tzvetkov, P Uhrin

2018-01-01

Abstract:
Vasculoprotective effects of pomegranate (Punica granatum L.)

Dongdong Wang, Cigdem Özen, Ibrahim M Abu-Reidah, Sridevi Chigurupati, Jayanta Kumar Patra, Jarosław O Horbanczuk, Pavel Uhrin, Atanas G Atanasov

2018-05-24

Abstract:Pomegranate (Punica granatum L.), one of the oldest known edible fruits, is nowadays broadly consumed throughout the world. Its fruits and seeds as well as other anatomical compartments (e.g., flowers and leaves) are rich in numerous bioactive compounds and therefore, the scientific interest in this plant has been constantly growing in recent years. It has been shown that pomegranate and its extracts exhibit potent antioxidative, antimicrobial, and anticarcinogenic properties. The present review summarizes some recent studies on pomegranate, highlighting mainly its vasculoprotective role attributed to the presence of hydrolyzable tannins ellagitannins and ellagic acid, as well as other compounds (e.g., anthocyanins and flavonoids). These in vitro and in vivo studies showed that substances derived from pomegranate reduce oxidative stress and platelet aggregation, diminish lipid uptake by macrophages, positively influence endothelial cell function, and are involved in blood pressure regulation. Clinical studies demonstrated that daily intake of pomegranate juice lessens hypertension and attenuates atherosclerosis in humans. Altogether, the reviewed studies point out the potential benefits of a broader use of pomegranate and its constituents as dietary supplements or as adjuvants in therapy of vascular diseases, such as hypertension, coronary artery disease, and peripheral artery disease.
Antiangiogenic Potential of Pomegranate Extracts

Riccardo Tornese,Anna Montefusco,Rocco Placì,Teodoro Semeraro,Miriana Durante,Monica De Caroli,Gianpiero Calabrese,Anna Eleonora Caprifico,Marcello Salvatore Lenucci

DOI: https://doi.org/10.3390/plants13233350

2024-11-29

Plants

Abstract:Pomegranate (Punica granatum L.) has long been recognised for its rich antioxidant profile and potential health benefits. Recent research has expanded its therapeutic potential to include antiangiogenic properties, which are crucial for inhibiting the growth of tumours and other pathological conditions involving aberrant blood vessel formation. This review consolidates current findings on the antiangiogenic effects of pomegranate extracts. We explore the impact of pomegranate polyphenols, including ellagic acid, punicalagin, anthocyanins, punicic acid and bioactive polysaccharides on key angiogenesis-related pathways and endothelial cell function. Emphasis is placed on the effects of these extracts as phytocomplexes rather than isolated compounds. Additionally, we discuss the use of pomegranate by-products, such as peels and seeds, in the preparation of extracts within a green chemistry and circular economy framework, highlighting their value in enhancing extract efficacy and sustainability. By primarily reviewing in vitro and in vivo preclinical studies, we assess how these extracts modulate angiogenesis across various disease models and explore their potential as adjunctive therapies for cancer and other angiogenesis-driven disorders. This review also identifies existing knowledge gaps and proposes future research directions to fully elucidate the clinical utility of pomegranate extracts in therapeutic applications.

plant sciences
Protective Effect of Punica granatum L. against Serum/Glucose Deprivation-Induced PC12 Cells Injury

Fatemeh Forouzanfar,Amir Afkhami Goli,Elham Asadpour,Ahmad Ghorbani,Hamid Reza Sadeghnia

DOI: https://doi.org/10.1155/2013/716730

2013-01-01

Abstract:The discovery and development of natural products with potent antioxidant, anti-inflammatory, and antiapoptotic properties have been one of the most interesting and promising approaches in the search for the treatment of many neurodegenerative diseases including ischemic stroke. Serum/glucose deprivation (SGD) has served as an excellent in vitro model for the understanding of the molecular mechanisms of neuronal damage during ischemia and for the development of neuroprotective drugs against ischemia-induced brain injury. Recent studies suggested that pomegranate ( Punica granatum L.) or its active constituents exert pharmacological actions such as antioxidant, anti-inflammatory, and neuroprotective properties. Therefore, in this study we investigated the possible protective effects of different extracts of pomegranate against SGD-induced PC12 cells injury. Initially, the cells were pretreated with different concentrations of pulp hydroalcoholic extract (PHE), pulp aqueous extract (PAE) and pomegranate juice (PJ) for 2 h and then deprived of serum/glucose (SGD) for 6 and 12 h. SGD caused a significant reduction in cell viability (measured by the MTT assay) after 6 and 12 h, as compared with control cells ( P < 0.001 ). Pretreatment with PHE, PAE, and PJ significantly and concentration-dependently increased cell viability following SGD insult for 6 and 12 h. A significant increase in DNA damage (measured by the comet assay) was seen in nuclei of cells following SGD for 12 h ( P < 0.001 ). In control groups, no significant difference was seen in DNA damage between PHE, PAE, and PJ-pretreated and vehicle-pretreated PC12 cells ( P > 0.05 ). PHE, PAE, and PJ pretreatment resulted in a significant decrease in DNA damage following ischemic insult ( P < 0.001 ). This suppression of DNA damage by PHE, PAE and PJ was found to be concentration dependent. These data indicate that there is a cytoprotective property in PHE, PAE, and PJ under SGD condition in PC12 cells, suggesting that pomegranate has the potential to be used as a new therapeutic strategy for neurodegenerative disorders.

integrative & complementary medicine
Antithrombotic activity of Punica granatum , L (Pomegranate): Experimental investigation and exploration of its mechanism of action on primary and secondary hemostasis in vitro and ex vivo

Fatima Zahra LAFDIL,Abdelkhaleq LEGSSYER,Abderrahim ZIYYAT,Ahmed KARIM,Ali BERRAAOUAN,Rachid SEDDIK,Hassane MEKHFI

DOI: https://doi.org/10.1016/j.molstruc.2024.140195

IF: 3.841

2024-10-02

Journal of Molecular Structure

Abstract:Hemostasis is the physiological process that stops bleeding by forming a thrombus (or blood clot). However, the inappropriate formation of a thrombus can constitute a pathophysiological event involving the same steps as those of hemostasis. Despite some adverse effects, antithrombotic therapy remains an effective means in the prevention and treatment of thrombotic diseases. In this regard, scientific research aimed at discovering new remedies of natural origin is particularly active.This study aims to evaluate the antithrombotic activity of the aqueous extract of Punica granatum peels in vivo . To understand the mechanism of action of this activity, we will investigate primary and secondary hemostasis in vitro and ex vivo . Furthermore, we will examine its antioxidant activity, toxicity, and phytochemical composition to identify the molecules responsible for the observed effects.The antithrombotic activity is assessed in vivo using the acute pulmonary thromboembolism model in mouse. Thrombosis is induced by injecting the thrombogenic solution (epinephrine + collagen) into the lateral caudal vein. Platelet aggregation, both in vitro and ex vivo , is performed on washed platelets isolated by centrifugation from rat blood. The platelet suspension is pre-incubated with the extract for 1 min. Aggregation is triggered by adding the following agonists: ADP, thrombin, collagen, and arachidonic acid. The bleeding time is measured in the absence and presence of the extract following an apical section of the mouse tail. This time corresponds to the duration of flow between the first and last drops of blood. To evaluate plasma coagulation, activated partial thromboplastin time (aPTT) and prothrombin time (PT) were measured under conditions both with and without the extract, using appropriate reagents. Acute toxicity is conducted by administering a single oral dose of the extract to mice (5 and 10 g kg -1 ). Possible changes in animal behavior are observed for fifteen days. The identification of polyphenols and flavonoids is performed by High Performance Liquid Chromatography (HPLC).The results obtained show that P. granatum exerted a significant preventive antithrombotic action (80 % protection) in mice. Furthermore, the extract inhibited platelet aggregation induced in vitro by all agonists in a dose-dependent manner, prolonged bleeding time, and coagulation times in rats. The results of the ex vivo study in rats confirmed these effects. We also noted that the extract did not exhibit toxicity following administration, and HPLC analysis revealed a richness of polyphenols and flavonoids in the extract. P. granatum exhibited an interesting antithrombotic activity, which could be attributed to its antiplatelet and anticoagulant actions. The phytochemical compounds identified in this extract could, at least in part, be responsible for these effects. Therefore, the demonstrated activities of this plant on hemostasis could lead to the development of more effective remedies and represent a means of prevention against thrombotic events.

chemistry, physical
Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5

Gulinigaer Anwaier,Guan Lian,Gui-Zhi Ma,Wan-Li Shen,Chih-I Lee,Pei-Ling Lee,Zhan-Ying Chang,Yun-Xia Wang,Xiao-Yu Tian,Xiao-Li Gao,Jeng-Jiann Chiu,Rong Qi

DOI: https://doi.org/10.3389/fcell.2021.697539

IF: 5.5

2021-06-28

Frontiers in Cell and Developmental Biology

Abstract:Background Pathophysiological vascular remodeling in response to disturbed flow with low and oscillatory shear stress (OSS) plays important roles in atherosclerosis progression. Pomegranate extraction (PE) was reported having anti-atherogenic effects. However, whether it can exert a beneficial effect against disturbed flow-induced pathophysiological vascular remodeling to inhibit atherosclerosis remains unclear. The present study aims at investigating the anti-atherogenic effects of pomegranate peel polyphenols (PPP) extraction and its purified compound punicalagin (PU), as well as their protective effects on disturbed flow-induced vascular dysfunction and their underlying molecular mechanisms. Methods The anti-atherogenic effects of PPP/PU were examined on low-density lipoprotein receptor knockout mice fed with a high fat diet. The vaso-protective effects of PPP/PU were examined in rat aortas using myograph assay. A combination of in vivo experiments on rats and in vitro flow system with human endothelial cells (ECs) was used to investigate the pharmacological actions of PPP/PU on EC dysfunction induced by disturbed flow. In addition, the effects of PPP/PU on vascular smooth muscle cell (VSMC) dysfunction were also examined. Results PU is the effective component in PPP against atherosclerosis. PPP/PU evoked endothelium-dependent relaxation in rat aortas. PPP/PU inhibited the activation of Smad1/5 in the EC layers at post-stenotic regions of rat aortas exposed to disturbed flow with OSS. PPP/PU suppressed OSS-induced expression of cell cycle regulatory and pro-inflammatory genes in ECs. Moreover, PPP/PU inhibited inflammation-induced VSMC dysfunction. Conclusion PPP/PU protect against OSS-induced vascular remodeling through inhibiting force-specific activation of Smad1/5 in ECs and this mechanism contributes to their anti-atherogenic effects.

cell biology,developmental biology
Therapeutic Benefits of Pomegranate Flower Extract: A Novel Effect That Reduces Oxidative Stress and Significantly Improves Diastolic Relaxation in Hyperglycemic In Vitro in Rats

Yuanyuan Wei,Ahmad Taha Khalaf,Peng Ye,Wei Fan,Junyi Su,Wanlu Chen,Hao Hu,Rashid Menhas,Lifeng Wang,Zahraa Oglah

DOI: https://doi.org/10.1155/2022/4158762

2022-06-08

Abstract:The pomegranate flower is an ancient herb in traditional Chinese medicine with multiple properties. Recent studies have shown that pomegranate flower extract is beneficial, especially for hyperglycemia. In this experiment, we investigated the diastolic effect of pomegranate flower polyphenol (PFP) extract on the isolated thoracic aorta of rats in both the absence and presence of high glucose levels. Isotonic contractile forces were recorded from aortic rings (about 3 mm in length) from rats using the BL-420F Biological Function Test System. Tissues were precontracted with 60 mM KCl to obtain maximum tension under 1.0 g load for 1 hour before the balance was achieved, and the fluid was changed every 15 minutes. PFP (700 mg/L-900 mg/L) showed a concentration-dependent relaxant effect on the aortic rings; vasodilation in the endothelium-intact was significantly higher than that in the de-endothelialized segments (P < 0.01). The endothelium-dependent vasorelaxant effect of PFP was partially attenuated by K+ channel blockers, tetraethylammonium (TEA), glibenclamide (Glib), and BaCl2, as well as L-NAME (eNOS inhibitor) on the denuded endothelium artery ring. Concentration-dependent inhibition of PFP on releasing intracellular Ca2+ in the Ca2+-free solution and vasoconstriction of CaCl2 in Ca2+-free buffer plus K+ (60 mM) was observed. In addition, PFP (0.1-10 mg/L) showed significant inhibition of acetylcholine-induced endothelial-dependent relaxation in the aorta of rats in the presence of high glucose (44 mmol/L). Nevertheless, the vasodilating effect of PFP was inhibited by atropine and L-NAME. The results indicated that PFP-induced vasodilation was most likely related to the antioxidant effects through enhanced NO synthesis, as well as the blocking of K+ channels and inhibition of extracellular Ca2+ entry. In conclusion, these observations showed that PFP ameliorates vasodilation in hyperglycemic rats. Hence, our results suggest that PFP supplementation may be beneficial for hypertensive patients with diabetes.
Hepatoprotective Potential of Pomegranate in Curbing the Incidence of Acute Liver Injury by Alleviating Oxidative Stress and Inflammatory Response

Hamid Ali,Azra Jahan,Samrana Samrana,Abid Ali,Safdar Ali,Nurul Kabir,Amjad Ali,Riaz Ullah,Ramzi A. Mothana,Bibi Nazia Murtaza,Muhammad Kalim

DOI: https://doi.org/10.3389/fphar.2021.694607

IF: 5.6

2021-11-26

Frontiers in Pharmacology

Abstract:Hepatitis is an inflammatory disease of the liver and is considered one of the leading causes of death worldwide. Due to its scavenging activity, Punica granatum may be used for the treatment and prevention of liver diseases. The current study investigated the protective mechanism underlying the effects of pomegranate against a rat model of carbon tetrachloride–induced liver injury. Intraperitoneal injection of CCl 4 resulted in liver inflammation, oxidative stress, and accumulation of lipid in hepatocytes. CCl 4 induced a downregulation of superoxide dismutase (SOD), glutathione (GSH), and melonaldehyde (MDA). Pomegranate protection was assessed in terms of biochemical parameters, histopathology, and immunohistochemistry. Promegranate administration decreased inflammation, elevated serum enzymes and ROS production, and countered the debilitating effects caused by CCl 4 . In addition, CCl 4 -induced histological changes were absent in the crude pomegranate extract group, which also enhanced the scavenging activity of reactive oxygen species by enhancing the antioxidant defense mechanism as confirmed by detecting MDA, SOD, and GSH expressions. The migration of CD68 + macrophages was halted at the injured area of the central vein and the number of macrophages was reduced to the normal control by the crude extract compared to the positive control silymarin group. Likewise, protective effects of ethylacetate and the aqueous fraction of the crude extract were also observed. However, the butanol and n -hexane fractions displayed increased levels of ALT, AST, and ALP as compared to silymarin. About 25% damage to hepatocytes was observed in the butanol and n -hexane group by histopathological examination, which is a little better compared to the CCl 4 -treated group. The crude extract and its ethyl acetate and aqueous fractions may be accountable for the hepatoprotective potential of Punica granatum , which was further confirmed by in vivo experiments. Together, these findings confirm that pomegranate exerts hepatoprotective activity against CCl 4 -induced oxidative stress and liver damage.

pharmacology & pharmacy
Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts

Zahra Amri,Ikram Ben Amor,Amira Zarrouk,Raja Chaaba,Jalel Gargouri,Mohamed Hammami,Sonia Hammami

DOI: https://doi.org/10.1186/s12906-022-03824-6

2022-12-27

Abstract:Background: Platelet aggregation and advanced glycation end products (AGEs) and oxidative stress are known as key factors for the development of cardiovascular diseases and diabetic complications. In this context, fruit and vegetable consumption, good sources of antioxidant compounds have been largely reported as an effective way of preventing human against these diseases. The current study focuses on the evaluation of antioxidant, antiplatelet and anti-glycation activities of pomegranate (Punica granatum L.) flowers (PF), leaves (PL), peel (PP) juice (PJ) and seeds oil (PSO). Methods: Antioxidant activities was measured against ABTS radical and lipid peroxidation. Antiglycation activity was determined using the formation of AGE fluorescence intensity in the BSA/ribose system. Antiplatelet activity was measured in platelet rich plasma (PRP) against adenosine diphosphate (ADP), Collagen and arachidonic acid (AA). Results: PF extract displayed the highest antioxidant activity against ABTS and lipid peroxidation with IC50 values of 0.7 mg/mL and 0.63 mg/mL respectively. For anti-glycation activity, PP, PF and PL inhibited moderately the pentosidine-like AGEs formation compared to positive controls with AGE-IC50 value of 0.4 mg/mL. PJ and PSO haven't any anti-AGE effect. All the extracts selectively inhibited platelet aggregation caused by one, two or three inducers in dose dependent manner. PF was the most potent inhibitor caused by all three inducers, with inhibitory effects ranging from 35.6 to 66.6%. PP and PJ exhibited antiplatelet effect against both ADP and collagen and PL and PSO only against AA. Conclusions: These results suggest that some pomegranate extracts exert potential in vitro anti-glycative and antiplatelet activities.
The Power of Punica granatum : A Natural Remedy for Oxidative Stress and Inflammation; a narrative review

Mahdis Moradnia,Niyoosha Mohammadkhani,Bayan Azizi,Mehdi Mohammadi,Sholeh Ebrahimpour,Ozra Tabatabaei-Malazy,Somayeh Mirsadeghi,Mahsa Ale-Ebrahim

DOI: https://doi.org/10.1016/j.jep.2024.118243

IF: 5.195

2024-04-27

Journal of Ethnopharmacology

Abstract:Ethnopharmacological relevance Pomegranate 'Punica granatum ' offers multiple health benefits, including managing hypertension, dyslipidemia, hyperglycemia, insulin resistance, and enhancing wound healing and infection resistance, thanks to its potent antioxidant and anti-inflammatory properties. It has been symbolized by life, health, femininity, fecundity, and spirituality. Aim of the study Although laboratory and animal studies have been conducted on the healing effects of pomegranate, there needs to be a comprehensive review on its anti-oxidative and anti-inflammatory effects in chronic disorders. We aim to provide a comprehensive review of these effects based on in-vitro, in-vivo, and clinical studies conducted in managing various disorders. Materials and methods A comprehensive search of in-vitro , in-vivo , and clinical findings of pomegranate and its derivatives focusing on the highly qualified original studies and systematic reviews are carried out in valid international web databases, including Web of Science, PubMed, Scopus, and Cochrane Library. Results Relevant studies have demonstrated that pomegranate and its derivatives can modulate the expression and activity of several genes, enzymes, and receptors through influencing oxidative stress and inflammation pathways. Different parts of pomegranate; roots, bark, blossoms, fruits, and leaves contain various bioactive compounds, such as polyphenols, flavonoids, anthocyanins, and ellagitannins, that have preventive and therapeutic effects against many disorders such as cardiovascular diseases, diabetes, neurological diseases, and cancers without any serious adverse effects. Conclusions Most recent scientific evidence indicates that all parts of the pomegranate can be helpful in treating a wide range of chronic disorders due to its anti-oxidative and anti-inflammatory activities. Since the safety of pomegranate fruit, juice, and extracts is established, further investigations can be designed by targeting its active antioxidant and anti-inflammatory constituents to discover new drugs.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Neuroprotective Potential of Punicalagin, a Natural Component of Pomegranate Polyphenols: A Review

Peng Chen,ZhiLei Guo,Benhong Zhou

DOI: https://doi.org/10.31083/j.jin2205113

2023-01-01

Journal of Integrative Neuroscience

Abstract:Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD) and Parkinson's disease (PD), are major health problems worldwide. To date, available remedies against NDs are limited. In fact, current treatment options include drug intervention and nutritional therapy, which mainly focus on the repair of neuronal damage and functional monitoring. However, these treatments do not completely alleviate disease symptoms. Recently, eliminating harmful molecules, such as reactive oxygen species, and inhibiting neuroinflammation have become potential strategies recommended by many researchers. Accordingly, remarkable interest has been generated in recent years regarding natural products, including polyphenols, that provide neuroprotective effects. In this review, we aimed to provide experimental evidence of the therapeutic potential of punicalagin (PUN), a prevailing compound in pomegranate polyphenols with antioxidant activity. Overall, the chemistry, methods of determination, characteristics of metabolism, transformation mechanisms of action, and neuroprotective effects of PUN on NDs are summarised to provide a scientific basis for elucidating the therapeutic mechanisms and targets of NDs.
Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review

Nhlanhla Maphetu,Jeremiah Oshiomame Unuofin,Nelisiwe Prenate Masuku,Chijioke Olisah,Sogolo Lucky Lebelo

DOI: https://doi.org/10.1016/j.biopha.2022.113256

Abstract:Punica granatum L (pomegranate) is one of the Mediterranean medicinal plants that has been used for generations in treating ulcers, diarrhea, and male infertility. Increasing evidence has revealed that pomegranate possesses myriads of pharmacological activities such as anti-diabetic, anti-tumor, anti-inflammatory, anti-malaria, anti-fibrotic, anti-fungal, anti-bacterial, and other effects. Consumption of pomegranate could be used to improve gut microbiota, and therefore prevent obesity and diabetes. The mechanisms of actions of pomegranate, mainly involve nuclear factor-erythroid factor 2-related factor 2 (Nrf2), nuclear factor kappa B (NF-kB), and mitogen-activated protein kinase (MAPK) signaling pathways. In recent times, in silico molecular docking studies demonstrated that pomegranate extract and or its phytochemicals are potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) spike protein and angiotensin-converting enzyme 2 (ACE2) receptor contact. Also, some clinical trials have indicated that pomegranate can be consumed for alleviation of non-alcoholic fatty liver disease, metabolic syndrome, dental infections, and menopausal symptoms. To date, active compounds, viz. alkaloids, anthocyanidins, tannins, flavonoids, phenolics, proanthocyanidins, sterols, terpenes, terpenoids, xanthonoids, fatty acids, organic acids, lignans, saccharides, and vitamin C have been isolated from pomegranate. Therefore, the current review article aimed to gather and presents an update on the ethnomedicinal uses, pharmacological activities, phytochemistry, and molecular mechanisms of Punica granatum L. This knowledge is of paramount importance in the future in drug discovery for the development of novel natural drugs for the treatment of various ailments.
Cell Type-Specific Anti- and Pro-Oxidative Effects of Punica granatum L. Ellagitannins

Ewa Olchowik-Grabarek,Szymon Sekowski,Iga Mierzwinska,Izabela Zukowska,Nodira Abdulladjanova,Vadim Shlyonsky,Maria Zamaraeva

DOI: https://doi.org/10.3390/membranes14100218

IF: 4.562

2024-10-16

Membranes

Abstract:Pomegranate and its by-products contain a broad spectrum of phytochemicals, such as flavonoids, phenolic acids and tannins, having pleiotropic preventive and prophylactic properties in health disorders related to oxidative stress and microbial contamination. Here, we examined the biological effects of a pomegranate peel ellagitannins-enriched (>90%) extract, PETE. In vitro studies revealed that PETE has a strong antiradical action towards synthetic radicals and biologically relevant ROS surpassing or comparable to that of Trolox. In cellular models, it showed concentration-dependent (25–100 μg/mL) yet opposing effects depending on the cell membrane type and exposure conditions. In erythrocytes, PETE protected membrane integrity in the presence of the strong oxidant HClO and restored reduced glutathione levels to up to 85% of the control value while having much weaker acute and long-term intrinsic effects. Such protection persisted even after the removal of the extract from cells, indicating strong membrane interaction. In HeLa cancer cells, and at concentrations lower than those used for red blood cells, PETE induced robust potentiation of ROS production and mitochondrial potential dissipation, leading to autophagy-like membrane morphology changes and cell death. In S. aureus, the growth arrest and bacterial death in the presence of PETE (with MIC = 31.25 μg/mL and MBC = 125 μg/mL, respectively) can be linked to the tripled ROS induction by the extract in the same concentration range. This study indicates a specificity of ROS production by the pomegranate extract depending on the type of cell, the concentration of the extract and the time of incubation. This specificity witnesses a strong potential of the extract components as candidates in antioxidant and pro-oxidant therapy.

engineering, chemical,materials science, multidisciplinary,polymer science,chemistry, physical
Punica granatum L. polysaccharides: A review on extraction, structural characteristics and bioactivities

Bin Zhao,Chunying Zhang,Tianshi Guo,Yan Wei

DOI: https://doi.org/10.1016/j.carres.2024.109246

2024-08-20

Abstract:Punica granatum L., commonly known as pomegranate, is native to Afghanistan and Iran, and today widely cultivated all over the world. Pomegranate polysaccharides are one of the most important bioactive components of P. granatum, which have a wide range of beneficial biological activities, such as anticancer, immunostimulatory, hepatoprotection, anti-psoriasis and antioxidation. Hot water extraction is currently the most commonly used method to isolate pomegranate polysaccharides. The structural characteristics of pomegranate polysaccharides have been extensively investigated through various advanced modern analytical techniques. This review focuses on the extraction, purification, structural characteristics, biological activities and structure-activity relationships of polysaccharides from Punica granatum. The aim of this article is to comprehensively and systematically summarize recent information of polysaccharides from Punica granatum and to serve as a basis for further research and development as therapeutic agents and functional foods.
Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation

Giada Benedetti,Lorenzo Flori,Jacopo Spezzini,Vincenzo Miragliotta,Giulia Lazzarini,Andrea Pirone,Cosimo Meneguzzo,Luca Tagliavento,Alma Martelli,Michele Antonelli,Davide Donelli,Cecilia Faraloni,Vincenzo Calderone,Francesco Meneguzzo,Lara Testai

DOI: https://doi.org/10.3390/nu16040506

IF: 5.9

2024-02-11

Nutrients

Abstract:The healthy properties of pomegranate fruit, a highly consumed food, have been known for a long time. However, the pomegranate supply chain is still rather inefficient, with the non-edible fraction, whose weight is roughly half the total and is endowed with plenty of valuable bioactive compounds, either disposed of or underutilized. A novel extract obtained from non-edible byproducts (called PPE), using hydrodynamic cavitation, a green, efficient, and scalable technique, was investigated for its cardiovascular effects in vivo. PPE showed efficacy in an acute phenylephrine (PE)-induced hypertensive rat model, similar to the extract of whole fruit (PFE) obtained using the same extractive technique, along with good intestinal bioaccessibility after oral administration. Finally, when chronically administered for 6 weeks to spontaneously hypertensive rats, PPE was shown to significantly contain the increase in systolic blood pressure, comparable to the reference drug Captopril, and at a dose remarkably lower than the reported effective dose of ellagic acid. The extract from the non-edible fraction of the pomegranate fruit also showed good anti-inflammation and anti-fibrotic effects. The findings of this study, along with the extraction technique, could contribute to enhancing the value of the pomegranate supply chain, relieve the related environmental burden, and potentially improve public health.

nutrition & dietetics
A Review Study on Punica granatum L

Erfaneh Shaygannia,Mahmoud Bahmani,Behnam Zamanzad,Mahmoud Rafieian-Kopaei

DOI: https://doi.org/10.1177/2156587215598039

2015-07-30

Abstract:Punica granatum L (pomegranate) is a deciduous shrub, native to Iran. Nowadays, besides its use as a fruit, its medicinal properties have attracted the interest of researchers of many countries. Pomegranate fruit has medicinal properties such as anti-inflammatory and antibacterial activities. The pomegranate seed oil has inhibitory effect on skin and breast cancers. The pomegranate seed oil has phytoestrogenic compounds and the fruit is rich in phenolic compounds with strong antioxidant activity. Ellagic acid is one of the main components of pomegranate with phenolic structure and antioxidant activity. This review article presents the recently published findings on different aspects of this plant focusing on its medicinal properties
Bioactive Compounds From The Seeds Of Punica Granatum (Pomegranate)

Rf Wang,Wd Xie,Z Zhang,Dm Xing,Y Ding,W Wang,C Ma,Lj Du

DOI: https://doi.org/10.1021/np0498051

IF: 5.1

2004-01-01

Journal of Natural Products

Abstract:Two new compounds, coniferyl 9-O-[beta-D-apiofuranosyl(1-->6)]-O-beta-D-glueopyranoside (1) and sinapyl 9-O-[beta-D-apiofuranosyl(1-->6)]-O-D-glucopyranoside (2), were isolated from the seeds of Punica granatum (pomegranate), together with five known compounds, 3,3'-di-O-methylellagic acid (3), 3,3',4'-tri-O-methylellagic acid (4), phenethyl rutinoside, icariside D-1, and daucosterol. The structures of 1 and 2 were elucidated by spectroscopic data analysis. Compounds 1-4 exhibited antioxidant activity, which was evaluated by measurement of low-density lipoprotein (LDL) susceptibility to oxidation and by determination in vitro of malondialdehyde (MDA) levels in the rat brain.
Pharmacokinetics and Ex‐vivo Bioactivties of Pomegranate Polyphenols in Humans

NP Seeram,S Henning,RP Lee,YT Niu,YJ Zhang,M Suchard,HS Scheuller,ZP Li,G Thames,D Heber

DOI: https://doi.org/10.1096/fasebj.20.5.a1019

2006-01-01

The FASEB Journal

Abstract:Pomegranate juice (PJ) contains abundant polyphenols including punicalagin, an ellagitannin (ET) that is largely responsible for its in vitro bioactivities. The pharmacokinetics (PK) of PJ polyphenols in human subjects remains uninvestigated. We evaluated PK parameters of PJ polyphenols in humans (n=19) after ingestion of PJ (180 mL containing 318 mg punicalagin). Blood was collected before and at 0.5, 1, 2, 3, 4, and 6h post administration. Urine (24 h) was collected on the day prior to ingestion, on the intervention day, and on the day after ingestion. Liquid chromatography mass spectroscopy (LC-MS) plasma analyses revealed ellagic acid (EA), a hydrolysis product of ETs, at Cmax = 18.64 ± 1.69 ng/mL, AUC = 50.07 ± 5.80 ng/h/mL, Tmax = 0.98 ± 0.059 h and T1/2E = 0.75 ± 0.078 h. LC-MS analyses of urine and plasma showed intact EA and EA-derivatives on the intervention day while further ET-breakdown products were detected on the post-ingestion day. Considerable inter-individual variability in metabolites was observed. Evaluation of biomarkers of oxidative stress by ex vivo plasma antioxidant status and lymphocyte 8-hydroxydeoxyguanosine to deoxyguanosine (8-OHdg/106dG) ratios (damage to lymphocyte DNA), did not show any significant differences after consumption of PJ. Our results provide useful data required for designing doses and dose frequencies in intervention studies with PJ polyphenols for purposes of evaluating their potential health benefits in humans. Supported by the Stewart and Lynda Resnick Revocable Trust.
An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate

Giada Benedetti,Federica Zabini,Luca Tagliavento,Francesco Meneguzzo,Vincenzo Calderone,Lara Testai

DOI: https://doi.org/10.3390/antiox12071351

IF: 7.675

2023-06-27

Antioxidants

Abstract:Pomegranate (Punica granatum L.) is a polyphenol-rich edible food and medicinal plant of ancient origin, containing flavonols, anthocyanins, and tannins, with ellagitannins as the most abundant polyphenols. In the last decades, its consumption and scientific interest increased, due to its multiple beneficial effects. Pomegranate is a balausta fruit, a large berry surrounded by a thick colored peel composed of exocarp and mesocarp with edible arils inside, from which the pomegranate juice can be produced by pressing. Seeds are used to obtain the seed oil, rich in fatty acids. The non-edible part of the fruit, the peel, although generally disposed as a waste or transformed into compost or biogas, is also used to extract bioactive products. This review summarizes some recent preclinical and clinical studies on pomegranate, which highlight promising beneficial effects in several fields. Although further insight is needed on key aspects, including the limited oral bioavailability and the role of possible active metabolites, the ongoing development of suitable encapsulation and green extraction techniques enabling the valorization of waste pomegranate products point to the great potential of pomegranate and its bioactive constituents as dietary supplements or adjuvants in therapies of cardiovascular and non-cardiovascular diseases.

biochemistry & molecular biology,chemistry, medicinal,food science & technology

Vasculoprotective effects of pomegranate (Punica granatumL.). Front Pharmacol. 2018; 9: 544

AG Atanasov Vasculoprotective effects of pomegranate (Punica granatum L.)., 2018, 9

Vasculoprotective effects of pomegranate (Punica granatum L.)

Antiangiogenic Potential of Pomegranate Extracts

Protective Effect of Punica granatum L. against Serum/Glucose Deprivation-Induced PC12 Cells Injury

Antithrombotic activity of Punica granatum , L (Pomegranate): Experimental investigation and exploration of its mechanism of action on primary and secondary hemostasis in vitro and ex vivo

Punicalagin Attenuates Disturbed Flow-Induced Vascular Dysfunction by Inhibiting Force-Specific Activation of Smad1/5

Therapeutic Benefits of Pomegranate Flower Extract: A Novel Effect That Reduces Oxidative Stress and Significantly Improves Diastolic Relaxation in Hyperglycemic In Vitro in Rats

Hepatoprotective Potential of Pomegranate in Curbing the Incidence of Acute Liver Injury by Alleviating Oxidative Stress and Inflammatory Response

Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts

The Power of Punica granatum : A Natural Remedy for Oxidative Stress and Inflammation; a narrative review

Neuroprotective Potential of Punicalagin, a Natural Component of Pomegranate Polyphenols: A Review

Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review

Cell Type-Specific Anti- and Pro-Oxidative Effects of Punica granatum L. Ellagitannins

Punica granatum L. polysaccharides: A review on extraction, structural characteristics and bioactivities

Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation

A Review Study on Punica granatum L

Bioactive Compounds From The Seeds Of Punica Granatum (Pomegranate)

Pharmacokinetics and Ex‐vivo Bioactivties of Pomegranate Polyphenols in Humans

An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate